These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30734)

  • 1. The antimicrobial activity of urine of paraplegic patients receiving methenamine mandelate.
    Pearman JW; Peterson GJ; Nash JB
    Invest Urol; 1978 Sep; 16(2):91-8. PubMed ID: 30734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde.
    Miller H; Phillips E
    Invest Urol; 1970 Jul; 8(1):21-33. PubMed ID: 4988376
    [No Abstract]   [Full Text] [Related]  

  • 3. Formaldehyde generation from methenamine salts in spinal cord injury.
    Devenport JK; Swenson JR; Dukes GE; Sonsalla PK
    Arch Phys Med Rehabil; 1984 May; 65(5):257-9. PubMed ID: 6712452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methenamine mandelate with acidification: an effective urinary antiseptic in patients with neurogenic bladder.
    Kevorkian CG; Merritt JL; Ilstrup DM
    Mayo Clin Proc; 1984 Aug; 59(8):523-9. PubMed ID: 6379319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methenamine mandelate: antimicrobial activity in urine and correlation with formaldehyde levels.
    Gandelman AL
    J Urol; 1967 Mar; 97(3):533-6. PubMed ID: 4960048
    [No Abstract]   [Full Text] [Related]  

  • 6. The generation of formaldehyde from methenamine. Effect of urinary flow and residual volume.
    Musher DM; Griffith DP; Richie Y
    Invest Urol; 1976 Mar; 13(5):380-2. PubMed ID: 1254431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy reviews: methenamine mandelate and methenamine hippurate.
    Gleckman R; Alvarez S; Joubert DW; Matthews SJ
    Am J Hosp Pharm; 1979 Nov; 36(11):1509-12. PubMed ID: 391033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of urine pH and ascorbic acid on the rate of conversion of methenamine to formaldehyde.
    Strom JG; Jun HW
    Biopharm Drug Dispos; 1993 Jan; 14(1):61-9. PubMed ID: 8427945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methenamine and its salts as urinary tract antiseptics: variables affecting the antibacterial activity of formaldehyde, mandelic acid, and hippuric acid in vitro.
    Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1977 Jan; 14(4):287-91. PubMed ID: 13049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy.
    Nahata MC; Cummins BA; McLeod DC; Schondelmeyer SW; Butler R
    Eur J Clin Pharmacol; 1982; 22(3):281-4. PubMed ID: 7106162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictability of methenamine efficacy based on type of urinary pathogen and pH.
    Nahata MC; Cummins BA; McLeod DC; Butler R
    J Am Geriatr Soc; 1981 May; 29(5):236-9. PubMed ID: 7014695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective determination of free urinary formaldehyde after oral dosage with methenamine mandelate.
    Chen TM; Chafetz L
    Invest Urol; 1972 Nov; 10(3):212-4. PubMed ID: 4640491
    [No Abstract]   [Full Text] [Related]  

  • 13. Methenamine hippurate in the treatment of urinary tract infections.
    Kasanen A; Mustakallio E; Koskinen EH; Soini V
    Ann Clin Res; 1974 Oct; 6(5):279-84. PubMed ID: 4614694
    [No Abstract]   [Full Text] [Related]  

  • 14. Simple additives to increase the activity of chlorhexidine digluconate against urinary pathogens.
    Harper WE
    Paraplegia; 1983 Apr; 21(2):86-93. PubMed ID: 6408586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary formaldehyde concentration after methenamine therapy in patients on intermittent catheterization.
    Nahata MC; Cummins BA; McLeod DC; Weichers DO
    J Fam Pract; 1983 Feb; 16(2):398, 400, 402. PubMed ID: 6822811
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect.
    Musher DM; Griffith DP
    Antimicrob Agents Chemother; 1974 Dec; 6(6):708-11. PubMed ID: 4451344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trial comparing co-trimoxazole and methenamine hippurate in the prevention of recurrent urinary tract infections.
    Kalowski S; Nanra RS; Friedman A; Radford N; Standish H; Kincaid-Smith P
    Med J Aust; 1975 May; 1(19):585-9. PubMed ID: 1152707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent bacteriuria in complete spinal cord injury patients on external condom drainage.
    Stover SL; Fleming WC
    Arch Phys Med Rehabil; 1980 Apr; 61(4):178-82. PubMed ID: 7369858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.